Metafora biosystems receives reimbursement for test to help diagnose De Vivo disease

Metafora biosystems receives reimbursement for test to help diagnose De Vivo disease

Paris, France, April 11, 2018 – Metafora biosystems, a company developing diagnostic tests to detect abnormalities in cellular energetics, today…